Delivery Order SPE2DB25D3003-SPE2DB26FPVFZ
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $8,598.16 to AmerisourceBergen Drug Corp for Enbrel 50 mg/mL SureClick auto-injector pens on October 30, 2025, with completion targeted for October 31, 2025. This firm fixed-price delivery order, executed without a set-aside designation, represents a competitive award under the company's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 and extending through December 2026. The...
- The Defense Logistics Agency awarded a $54,357.69 firm fixed price delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for Enbrel 50 mg/mL SureClick auto-injector pens. This non-set-aside contract is a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The product will be performed at AmerisourceBergen's corporate headquarters location in Conshohocken,...
- The Defense Logistics Agency awarded a $4,626.78 firm fixed-price delivery order to AmerisourceBergen Drug Corp for ENBREL 50 mg/ml SureClick auto-injector pens, with an ultimate completion date of October 30, 2025. This non-competitive delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. The pharmaceutical product will be delivered to the contractor's...
- The Defense Logistics Agency awarded a $11,055.36 firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 25, 2025, for the supply of Enbrel 50 mg/ml SureClick auto-injectors. The delivery order, which represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX, valued at $999,999,999.00 through December 2026), will be fulfilled from the contractor's facility in Conshohocken, Pennsylvania, with an ultimate...
- The Defense Logistics Agency awarded a delivery order valued at $10,226.52 to AmerisourceBergen Drug Corp for the supply of Enbrel 50 mg/mL SureClick auto-injector pens. This firm fixed-price delivery order was competitively awarded without set-aside designation and is scheduled for completion by July 21, 2025. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters and pharmaceutical distribution...
- The Defense Logistics Agency awarded a delivery order valued at approximately $37,038 to AmerisourceBergen Drug Corp on September 4, 2025, for the supply of Enbrel 50 mg/ml SureClick auto-injector pens. This is a firm fixed price, competitively awarded contract with no set-aside designation, with ultimate completion scheduled for September 5, 2025. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a...
- The Defense Logistics Agency awarded a $18,182.30 delivery order to AmerisourceBergen Drug Corp for Enbrel 50 mg/mL SureClick auto-injector pens, with performance in Conshohocken, Pennsylvania and completion by September 16, 2025. This is a firm fixed-price, non-set-aside contract awarded on September 15, 2025. The delivery order represents a child contract under AmerisourceBergen's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and...
- The Defense Logistics Agency awarded a $10,913.86 firm fixed price delivery order to AmerisourceBergen Drug Corp for ENBREL 50 mg/ml SureClick auto-injector pens, with an ultimate completion date of September 26, 2025. This non-set-aside contract was competitively awarded and is being fulfilled from AmerisourceBergen's location in Conshohocken, Pennsylvania. The delivery order is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The Defense Logistics Agency awarded a delivery order valued at $11,857.96 to AmerisourceBergen Drug Corp for Enbrel 50 mg/ml SureClick auto-injector pens, with performance completed in Conshohocken, Pennsylvania. The contract, awarded on August 13, 2025, with an ultimate completion date of August 14, 2025, utilized firm fixed-price pricing under a non-competitive set-aside arrangement. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a $10,820.21 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Enbrel 50 mg/mL SureClick auto-injectors, with a completion deadline of September 30, 2025. This non-competed delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. The company, headquartered in Conshohocken, Pennsylvania, serves as...
- SPE2DB25D3003Indefinite Delivery Contract
- SPE2DB25D3003-SPE2DB26FPVFZDelivery Order
The Defense Logistics Agency awarded a $9,253.56 firm fixed-price delivery order to AmerisourceBergen Drug Corp on November 7, 2025, for the supply of Enbrel 50 mg/mL SureClick auto-injector pens. This non-set-aside delivery order represents a child contract under AmerisourceBergen's substantial indefinite delivery/indefinite quantity (IDIQ) vehicle with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and running through December 2026. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, with completion targeted for November 10, 2025. As a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, AmerisourceBergen Drug Corp serves as a critical vendor for federal medical procurement, supplying a comprehensive range of brand-name and generic medications, vaccines, and specialized medical devices to military and veteran healthcare systems. The company's DLA Troop Support Medical prime contract functions as a global pharmaceutical support vehicle enabling supply of critical medical commodities across multiple therapeutic domains to customers including the Defense Health Agency and the U.S. Coast Guard. The current delivery order for Enbrel, a biologic immunosuppressant used to treat rheumatoid arthritis and other inflammatory conditions, reflects the company's ongoing role in supporting military medical supply chains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $9.3k | 11/7/25 |